Efficacy of bisacodyl suppository versus standard care in enhancing early recovery post cesarean section: A randomised controlled trial at Irrua Specialist Teaching Hospital, Irrua

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202512709170316

Enrollment

172

Registered

2025-12-04

Start date

2026-01-04

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy and Childbirth

Interventions

Standard care

Bisacodyl Suppository

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: All consenting pregnant women undergoing either elective or emergency caesarean section during the study period

Exclusion criteria

Exclusion criteria: Caesarean section done under general anaesthesia Women with known gastrointestinal disorders. Women with history of chronic constipation or previous bowel surgery. Women with allergy to Bisacodyl Women who had complicated surgeries with extended recovery periods

Design outcomes

Primary

Measure	Time frame
Time to first bowel movement (in hours).	—

Secondary

Measure	Time frame
Time to oral feeding and ambulation. Patient comfort and satisfaction scores. Any recorded side effects of use of bisacodyl	—

Countries

Nigeria

Contacts

Public ContactOmosefe Evbuomwan

Association of Resident Doctors

omosefeevbuomwan@gmail.com+2348030536581

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026